In vitro susceptibility of Staphylococcus aureus and coagulase-negative Staphylococcus strains to fusidic acid
dc.contributor.author | Tünger O. | |
dc.contributor.author | Arsoy A. | |
dc.contributor.author | Kurutepe S. | |
dc.contributor.author | Akçal S. | |
dc.contributor.author | Özbakkalolu B. | |
dc.date.accessioned | 2024-07-22T08:25:28Z | |
dc.date.available | 2024-07-22T08:25:28Z | |
dc.date.issued | 2001 | |
dc.description.abstract | [No abstract available] | |
dc.identifier.DOI-ID | 10.1016/S0924-8579(01)00433-2 | |
dc.identifier.issn | 09248579 | |
dc.identifier.uri | http://akademikarsiv.cbu.edu.tr:4000/handle/123456789/20443 | |
dc.language.iso | English | |
dc.subject | Anti-Bacterial Agents | |
dc.subject | Coagulase | |
dc.subject | Cross Infection | |
dc.subject | Drug Resistance, Bacterial | |
dc.subject | Fusidic Acid | |
dc.subject | Humans | |
dc.subject | Methicillin Resistance | |
dc.subject | Microbial Sensitivity Tests | |
dc.subject | Staphylococcal Infections | |
dc.subject | Staphylococcus aureus | |
dc.subject | antibiotic agent | |
dc.subject | beta lactam | |
dc.subject | fusidate sodium | |
dc.subject | fusidic acid | |
dc.subject | glycopeptide | |
dc.subject | meticillin | |
dc.subject | vancomycin | |
dc.subject | antibiotic resistance | |
dc.subject | antibiotic sensitivity | |
dc.subject | antimicrobial activity | |
dc.subject | coagulase negative Staphylococcus | |
dc.subject | dilution | |
dc.subject | drug bioavailability | |
dc.subject | drug diffusion | |
dc.subject | drug mechanism | |
dc.subject | hospital infection | |
dc.subject | human | |
dc.subject | in vitro study | |
dc.subject | letter | |
dc.subject | methicillin resistant Staphylococcus aureus | |
dc.subject | nonhuman | |
dc.subject | penicillin resistance | |
dc.subject | priority journal | |
dc.subject | Staphylococcus infection | |
dc.title | In vitro susceptibility of Staphylococcus aureus and coagulase-negative Staphylococcus strains to fusidic acid | |
dc.type | Letter |